Patrick Fagan

743 total citations
16 papers, 606 citations indexed

About

Patrick Fagan is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Patrick Fagan has authored 16 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Patrick Fagan's work include HIV/AIDS drug development and treatment (5 papers), Click Chemistry and Applications (3 papers) and Biochemical and Molecular Research (3 papers). Patrick Fagan is often cited by papers focused on HIV/AIDS drug development and treatment (5 papers), Click Chemistry and Applications (3 papers) and Biochemical and Molecular Research (3 papers). Patrick Fagan collaborates with scholars based in United States and Italy. Patrick Fagan's co-authors include Peppi Prasit, Charles W. Chapman, Jennifer L. Brooks, P. Dan Cook, Marija Prhavc, Janet M. Leeds, Kristen M. Smith, Thomas W. Bruice, Colin Walsh and Vivek K. Rajwanshi and has published in prestigious journals such as Nature Cell Biology, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Patrick Fagan

16 papers receiving 575 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Fagan United States 11 334 130 112 84 77 16 606
Huihong You United States 10 274 0.8× 111 0.9× 56 0.5× 22 0.3× 38 0.5× 13 522
Daniel Floryk United States 13 406 1.2× 36 0.3× 36 0.3× 103 1.2× 69 0.9× 17 568
Mariola Sadowska United States 16 279 0.8× 62 0.5× 71 0.6× 83 1.0× 160 2.1× 28 789
Deidre Wilkins United States 15 282 0.8× 150 1.2× 80 0.7× 102 1.2× 215 2.8× 29 745
Ashish Saroha India 15 313 0.9× 97 0.7× 120 1.1× 49 0.6× 54 0.7× 18 561
Alan K. Ikeda United States 11 396 1.2× 58 0.4× 41 0.4× 23 0.3× 84 1.1× 20 614
Lingyu Li China 15 273 0.8× 141 1.1× 190 1.7× 29 0.3× 64 0.8× 35 785
Nathaniel C. Sears United States 8 337 1.0× 24 0.2× 106 0.9× 48 0.6× 53 0.7× 14 681
Kathryn Mazina United States 14 426 1.3× 106 0.8× 40 0.4× 25 0.3× 65 0.8× 20 602

Countries citing papers authored by Patrick Fagan

Since Specialization
Citations

This map shows the geographic impact of Patrick Fagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Fagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Fagan more than expected).

Fields of papers citing papers by Patrick Fagan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Fagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Fagan. The network helps show where Patrick Fagan may publish in the future.

Co-authorship network of co-authors of Patrick Fagan

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Fagan. A scholar is included among the top collaborators of Patrick Fagan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Fagan. Patrick Fagan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Yokoyama, Yumi, Erin D. Lew, Ruth Seelige, et al.. (2019). Immuno-oncological Efficacy of RXDX-106, a Novel TAM (TYRO3, AXL, MER) Family Small-Molecule Kinase Inhibitor. Cancer Research. 79(8). 1996–2008. 70 indexed citations
2.
Fagan, Patrick, Chan Lee, Sung Eun Kim, et al.. (2018). RIPK1-mediated induction of mitophagy compromises the viability of extracellular-matrix-detached cells. Nature Cell Biology. 20(3). 272–284. 74 indexed citations
3.
Tao, Jessica J., Wei Ge, Roopal Patel, et al.. (2018). ALK Fusions in Renal Cell Carcinoma: Response to Entrectinib. JCO Precision Oncology. 2(2). 1–8. 28 indexed citations
4.
Smith, Kristen M., Patrick Fagan, Elena Pomari, et al.. (2017). Antitumor Activity of Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor, in ETV6-NTRK3 –Positive Acute Myeloid Leukemia. Molecular Cancer Therapeutics. 17(2). 455–463. 33 indexed citations
5.
Fagan, Patrick, Colin Walsh, Danielle Murphy, et al.. (2017). Abstract 5158: Anti-tumor activity of entrectinib, a highly potent pan-TRK, ROS1 and ALK inhibitor, in molecularly defined acute myeloid leukemia. Cancer Research. 77(13_Supplement). 5158–5158. 2 indexed citations
6.
Ge, Wei, Roopal Patel, C J Walsh, et al.. (2016). Entrectinib, a highly potent pan-Trk, ROS1, and ALK inhibitor, has broad-spectrum, histology-agnostic anti-tumor activity in molecularly defined cancers. European Journal of Cancer. 69. S33–S33. 4 indexed citations
7.
Fagan, Patrick, et al.. (2014). Breast cancer and induced abortion: a comprehensive review of breast development and pathophysiology, the epidemiologic literature, and proposal for creation of databanks to elucidate all breast cancer risk factors.. PubMed. 29(1). 3–133. 2 indexed citations
8.
Baccei, Christopher, Gretchen Bain, Jilly F. Evans, et al.. (2011). Discovery and optimization of a biphenylacetic acid series of prostaglandin D2 receptor DP2 antagonists with efficacy in a murine model of allergic rhinitis. Bioorganic & Medicinal Chemistry Letters. 21(21). 6608–6612. 3 indexed citations
9.
Chapman, Charles W., et al.. (2010). A novel, orally active LPA 1 receptor antagonist inhibits lung fibrosis in the mouse bleomycin model. British Journal of Pharmacology. 160(7). 1699–1713. 205 indexed citations
10.
Stearns, Brian A., Christopher Baccei, Gretchen Bain, et al.. (2009). Novel tricyclic antagonists of the prostaglandin D2 receptor DP2 with efficacy in a murine model of allergic rhinitis. Bioorganic & Medicinal Chemistry Letters. 19(16). 4647–4651. 37 indexed citations
11.
Stebbins, Karin J., Christopher Baccei, Heather Coate, et al.. (2009). Pharmacological Blockade of the DP2 Receptor Inhibits Cigarette Smoke-Induced Inflammation, Mucus Cell Metaplasia, and Epithelial Hyperplasia in the Mouse Lung. Journal of Pharmacology and Experimental Therapeutics. 332(3). 764–775. 40 indexed citations
12.
Fagan, Patrick, et al.. (2005). 2′,3′-Dideoxynucleoside 5′-β,γ-(Difluoromethylene) Triphosphates With α-P-Thio or α-P-Seleno Modifications: Synthesis and Their Inhibition of HIV-1 Reverse Transcriptase. Nucleosides Nucleotides & Nucleic Acids. 24(10-12). 1651–1664. 10 indexed citations
13.
Rajwanshi, Vivek K., Marija Prhavc, Patrick Fagan, et al.. (2005). Synthesis of 5′-Triphosphate Mimics (P3Ms) of 3′-Azido-3′,5′-Dideoxythymidine and 3′,5′-Dideoxy-5′-Difluoromethylenethymidine as HIV-1 Reverse Transcriptase Inhibitors. Nucleosides Nucleotides & Nucleic Acids. 24(3). 179–189. 5 indexed citations
14.
Rajwanshi, Vivek K., Marija Prhavc, Guangyi Wang, et al.. (2005). Synthesis of 2‘,3‘-Dideoxynucleoside 5‘-α-P-Borano-β,γ-(difluoromethylene)triphosphates and Their Inhibition of HIV-1 Reverse Transcriptase. Journal of Medicinal Chemistry. 48(7). 2695–2700. 28 indexed citations
15.
Wang, Guangyi, Nicholas Boyle, Chen Fu, et al.. (2004). Synthesis of AZT 5‘-Triphosphate Mimics and Their Inhibitory Effects on HIV-1 Reverse Transcriptase. Journal of Medicinal Chemistry. 47(27). 6902–6913. 53 indexed citations
16.
Wang, Guangyi, Kandasamy Sakthivel, Thomas W. Bruice, et al.. (2004). Synthesis of Azole Nucleoside 5′‐Monophosphate Mimics (P1Ms) and Their Inhibitory Properties of IMP Dehydrogenases. Nucleosides Nucleotides & Nucleic Acids. 23(1-2). 317–337. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huihong You Breakdown of academic impact, for papers by Daniel Floryk Breakdown of academic impact, for papers by Mariola Sadowska Breakdown of academic impact, for papers by Deidre Wilkins Breakdown of academic impact, for papers by Ashish Saroha Breakdown of academic impact, for papers by Alan K. Ikeda Breakdown of academic impact, for papers by Lingyu Li Breakdown of academic impact, for papers by Nathaniel C. Sears Breakdown of academic impact, for papers by Kathryn Mazina
Rankless by CCL
2026